fusidic acid has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FE; Guo, HY; Huang, X; Liu, Z; Quan, YS; Quan, ZS; Shen, QK; Zhang, LW | 1 |
| Guo, HY; Huang, X; Liu, Z; Quan, ZS; Shen, QK | 1 |
2 other study(ies) available for fusidic acid and Lung Injury, Acute
| Article | Year |
|---|---|
Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Extracellular Signal-Regulated MAP Kinases; Fusidic Acid; Inflammasomes; Interleukin-6; Lipopolysaccharides; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Tumor Necrosis Factor-alpha | 2023 |
Synthesis and structure-activity relationship studies of fusidic acid derivatives as anti-inflammatory agents for acute lung injury.
Topics: Acute Lung Injury; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Cyclooxygenase 2; Cytokines; Fusidic Acid; Humans; Lipopolysaccharides; NF-kappa B; Structure-Activity Relationship | 2023 |